Overview of Apitherapy Products: Anti-Cancer Effects of Bee Venom Used in Apitherapy

Year 2021, Volume: 2 Issue: 1, 36 - 48, 15.04.2021

Fatma Şengül , Hüsamettin Vatansev

Abstract

While Brazil and the United States of America are in the first place in world Apitherapy research, our country is in the fifth place after Japan and China. While the studies on apitherapy are continuing rapidly in the world, it has started to become widespread in our country especially in 2014 with the regulation of traditional and complementary medicine practices, and Apitherapy units and application centers have started to be established. Apitherapy is the use of bee products to protect and improve health, to strengthen the immune system and to complement the treatment process of some diseases. While bee products such as honey, propolis, bee pollen have been known and used for a long time, studies on apilarnil, royal jelly and bee venom have started to increase in recent years. These products have been used both as foodstuffs and as a source of healing from wound healing to anticancer effect for many years due to their rich content. With scientific studies, the interest in apitherapy products has increased even more.
Cancer is known as the leading cause of death in our country and all over the world. Side effects, costs, etc. Such adverse conditions have led researchers to research natural treatment methods. These natural treatments are used to increase the effectiveness of existing traditional treatments. In this review, literature information about Apitherapy, which is one of the traditional and complementary medicine applications, chemical content and physiological effects of bee products, is given and the therapeutic effect of bee venom on cancer is mentioned. Studies on the anticancer activity of bee venom in almost all types of cancer have been conducted and promising results have been obtained. This situation indicates that this apitherapeutic product will take place as a supplement in cancer treatment in the near future.

Keywords

Apitherapy, bee venom, honey, propolis, neoplasms, traditional medicine

Supporting Institution

There are no individuals or organizations that financially support the study.

Project Number

No.

Thanks

No.

References

• 1. Yeşilada E. [Apiterapi Arıyla Gelen Şifa]. 1 ed. İstanbul: Hayykitap; 2015.
• 2. Schmidt JO. Bee Products. In: Mizrahi A, Lensky Y, eds. Bee Products: Properties, Applications, and Apitherapy. Boston, MA: Springer US; 1997:15-26.
• 3. Enstitüsü TS. TSE 3036 Bal Standardı. In. Ankara2010.
• 4. Commission CA. Revised codex standard for honey. Codex Stan. 2001:12-1981.
• 5. Ferreira IC, Aires E, Barreira JC, Estevinho LM. Antioxidant activity of Portuguese honey samples: Different contributions of the entire honey and phenolic extract. Food Chemistry. 2009;114(4):1438-1443.
• 6. da C Azeredo L, Azeredo M, De Souza S, Dutra V. Protein contents and physicochemical properties in honey samples of Apis mellifera of different floral origins. Food chemistry. 2003;80(2):249-254.
• 7. Iglesias MT, De Lorenzo C, Polo MdC, Martín-Álvarez PJ, Pueyo E. Usefulness of amino acid composition to discriminate between honeydew and floral honeys. Application to honeys from a small geographic area. Journal of agricultural and food chemistry. 2004;52(1):84-89.
• 8. Bogdanov S, Jurendic T, Sieber R, Gallmann P. Honey for nutrition and health: a review. Journal of the American College of Nutrition. 2008;27(6):677-689.
• 9. Escuredo O, Míguez M, Fernández-González M, Carmen Seijo M. Nutritional value and antioxidant activity of honeys produced in a European Atlantic area. Food Chemistry. 2013;138(2):851-856.
• 10. Escuredo O, Dobre I, Fernández-González M, Seijo MC. Contribution of botanical origin and sugar composition of honeys on the crystallization phenomenon. Food chemistry. 2014;149:84-90.
• 11. Cuevas-Glory LF, Pino JA, Santiago LS, Sauri-Duch E. A review of volatile analytical methods for determining the botanical origin of honey. Food Chemistry. 2007;103(3):1032-1043.
• 12. Ulusoy E. Bal ve apiterapi. Uludağ Arıcılık Dergisi. 2012;12(3):89-97.
• 13. Efem S. Clinical observations on the wound healing properties of honey. British journal of Surgery. 1988;75(7):679-681.
• 14. Ali A, Chowdhury M, Al Humayyd M. Inhibitory effect of natural honey on Helicobacter pylori. Tropical gastroenterology: official journal of the Digestive Diseases Foundation. 1991;12(3):139-143.
• 15. Mandal MD, Mandal S. Honey: its medicinal property and antibacterial activity. Asian Pacific journal of tropical biomedicine. 2011;1(2):154-160.
• 16. Cianciosi D, Forbes-Hernández TY, Afrin S, et al. Phenolic compounds in honey and their associated health benefits: A review. Molecules. 2018;23(9):2322.
• 17. Al-Mamary M, Al-Meeri A, Al-Habori M. Antioxidant activities and total phenolics of different types of honey. Nutrition Research. 2002;22(9):1041-1047.
• 18. Gheldof N, Wang X-H, Engeseth NJ. Identification and quantification of antioxidant components of honeys from various floral sources. Journal of agricultural and food chemistry. 2002;50(21):5870-5877.
• 19. Erejuwa OO, Sulaiman SA, Ab Wahab MS. Honey: a novel antioxidant. Molecules. 2012;17(4):4400-4423.
• 20. Poljsak B, Šuput D, Milisav I. Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxidative medicine and cellular longevity. 2013;2013.
• 21. Molan PC. Potential of honey in the treatment of wounds and burns. American journal of clinical dermatology. 2001;2(1):13-19.
• 22. Gómez-Caravaca A, Gómez-Romero M, Arráez-Román D, Segura-Carretero A, Fernández-Gutiérrez A. Advances in the analysis of phenolic compounds in products derived from bees. Journal of Pharmaceutical and Biomedical Analysis. 2006;41(4):1220-1234.
• 23. Estevinho L, Pereira AP, Moreira L, Dias LG, Pereira E. Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey. Food Chem Toxicol. 2008;46(12):3774-3779.
• 24. Alvarez-Suarez JM, Tulipani S, Romandini S, Bertoli E, Battino M. Contribution of honey in nutrition and human health: a review. Mediterranean Journal of Nutrition and Metabolism. 2010;3(1):15-23.
• 25. Shambaugh P, Worthington V, Herbert J. Differential effects of honey, sucrose, and fructose on blood sugar levels. Journal of manipulative and physiological therapeutics. 1990;13(6):322-325.
• 26. Castaldo S, Capasso F. Propolis, an old remedy used in modern medicine. Fitoterapia. 2002;73:S1-S6.
• 27. Semiramis KUTLUCA FG, Ali KORKMAZ. PROPOLİS. In: Samsun: T.C. SAMSUN VALİLİĞİ İl Tarım Müdürlüğü; 2008.
• 28. Doğan H, Silici S, Ozcimen AA. Biological Effects of Propolis on Cancer. Turkish Journal of Agriculture-Food Science and Technology. 2020;8(3):573-579.
• 29. Burdock GA. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol. 1998;36(4):347-363.
• 30. Bankova VS, de Castro SL, Marcucci MC. Propolis: recent advances in chemistry and plant origin. Apidologie. 2000;31(1):3-15.
• 31. Dobrowolski JW, Vohora S, Sharma K, Shah SA, Naqvi S, Dandiya P. Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products. Journal of ethnopharmacology. 1991;35(1):77-82.
• 32. Banskota AH, Tezuka Y, Kadota S. Recent progress in pharmacological research of propolis. Phytotherapy research. 2001;15(7):561-571.
• 33. Sforcin JM, Bankova V. Propolis: is there a potential for the development of new drugs? Journal of ethnopharmacology. 2011;133(2):253-260.
• 34. Villanueva MO, Marquina AD, Serrano RB, Abellán GB. The importance of bee-collected pollen in the diet: a study of its composition. International Journal of Food Sciences and Nutrition. 2002;53(3):217-224.
• 35. Bogdanov S. Pollen: Collection, Harvest, Compostion, Quality. 2016.
• 36. Pascoal A, Rodrigues S, Teixeira A, Feás X, Estevinho LM. Biological activities of commercial bee pollens: Antimicrobial, antimutagenic, antioxidant and anti-inflammatory. Food Chem Toxicol. 2014;63:233-239.
• 37. Güneş M.E. OHH. Arı Ürünleri, Arı Sokması ve Veteriner Apiterapi. In: Doğanay A. AL, ed. Bal Arısı: Yetiştiriciliği, Ürünleri, Hastalıkları. 1 ed. Bursa: Dora Yayınevi; 2017:170-171.
• 38. Nogueira C, Iglesias A, Feás X, Estevinho LM. Commercial bee pollen with different geographical origins: a comprehensive approach. Int J Mol Sci. 2012;13(9):11173-11187.
• 39. da Silva GR, da Natividade TB, Camara CA, da Silva EMS, dos Santos FdAR, Silva TMS. Identification of sugar, amino acids and minerals from the pollen of Jandaíra stingless bees (Melipona subnitida). Food and Nutrition Sciences. 2014;2014.
• 40. Denisow B, Denisow‐Pietrzyk M. Biological and therapeutic properties of bee pollen: a review. Journal of the Science of Food and Agriculture. 2016;96(13):4303-4309.
• 41. Ulbricht C, Conquer J, Giese N, et al. An evidence-based systematic review of bee pollen by the Natural Standard Research Collaboration. J Diet Suppl. 2009;6(3):290-312.
• 42. Komosinska-Vassev K, Olczyk P, Kaźmierczak J, Mencner L, Olczyk K. Bee pollen: chemical composition and therapeutic application. Evidence-based complementary and alternative medicine : eCAM. 2015;2015:297425-297425.
• 43. Campos MGR, Frigerio C, Lopes J, Bogdanov S. What is the future of Bee-Pollen. Journal of ApiProduct and ApiMedical Science. 2010;2(4):131-144.
• 44. Küpeli Akkol E, Orhan DD, Gürbüz I, Yesilada E. In vivo activity assessment of a “honey-bee pollen mix” formulation. Pharm Biol. 2010;48(3):253-259.
• 45. Yakusheva E. Pollen and bee bread: physico-chemical properties. Biological and pharmacological effects. Use in medical practice. Theoretical and Practical Basics of Apitherapy. 2010:84-97.
• 46. Campos MG, Bogdanov S, de Almeida-Muradian LB, et al. Pollen composition and standardisation of analytical methods. Journal of Apicultural Research. 2008;47(2):154-161.
• 47. Rzepecka-Stojko A, Stojko J, Kurek-Górecka A, et al. Polyphenols from bee pollen: structure, absorption, metabolism and biological activity. Molecules. 2015;20(12):21732-21749.
• 48. Ares AM, Valverde S, Bernal JL, Nozal MJ, Bernal J. Extraction and determination of bioactive compounds from bee pollen. Journal of Pharmaceutical and Biomedical Analysis. 2018;147:110-124.
• 49. Bogdanov S. Pollen: nutrition, functional properties, health: a review. Bee Product Science. 2011:1-34.
• 50. Mutsaers M. Bee products: properties, processing and marketing. Agromisa Foundation/Technical Centre for Agricultural and Rural Cooperation …; 2005.
• 51. Khalifa SAM, Elashal M, Kieliszek M, et al. Recent insights into chemical and pharmacological studies of bee bread. Trends in Food Science & Technology. 2020;97:300-316.
• 52. Havas LJ. Effect of bee venom on colchicine-induced tumours. Nature. 1950;166(4222):567-568.
• 53. Bogdanov S. Royal jelly, bee brood: composition, health, medicine: a review. Lipids. 2011;3(8):8-19.
• 54. Giroud B, Vauchez A, Vulliet E, Wiest L, Buleté A. Trace level determination of pyrethroid and neonicotinoid insecticides in beebread using acetonitrile-based extraction followed by analysis with ultra-high-performance liquid chromatography–tandem mass spectrometry. Journal of Chromatography A. 2013;1316:53-61.
• 55. Ivanišová E, Kačániová M, Frančáková H, et al. Bee bread-perspective source of bioactive compounds for future. Potravinarstvo Slovak Journal of Food Sciences. 2015;9(1):592-598.
• 56. Nagai T, Nagashima T, Myoda T, Inoue R. Preparation and functional properties of extracts from bee bread. Food/nahrung. 2004;48(3):226-229.
• 57. Baltrušaitytė V, Venskutonis PR, Čeksterytė V. Antibacterial activity of honey and beebread of different origin against S. aureus and S. epidermidis. Food Technology and Biotechnology. 2007;45(2):201-208.
• 58. Abouda Z, Zerdani I, Kalalou I, Faid M, Ahami M. The antibacterial activity of Moroccan bee bread and bee-pollen (fresh and dried) against pathogenic bacteria. Research Journal of Microbiology. 2011;6(4):376.
• 59. Sobral F, Calhelha RC, Barros L, et al. Flavonoid composition and antitumor activity of bee bread collected in northeast Portugal. Molecules. 2017;22(2):248.
• 60. National Health Commission of the People's Republic of China. Notice on diagnosis and treatment of novel coronavirus pneumonia (Trial Version 7) [EB/OL] (2020-03-03) . https://med.sina.cn/article_detail_103_1_78534.html (in Chinese).
• 61. Šimúth J. Some properties of the main protein of honeybee (Apis mellifera) royal jelly. 2001.
• 62. Crane E. The past and present status of beekeeping with stingless bees. Bee world. 1992;73(1):29-42.
• 63. Takenaka T. Nitrogen components and carboxylic acids of royal jelly. Chemistry and biology of social insects. 1987:162-163.
• 64. Vecchi M, Sabatini A, Grazia L, Tini V, Zambonelli C. Il contenuto in vitamine come possibile elemento di caratterizzazione della gelatina reale. 1988.
• 65. Viuda-Martos M, Ruiz-Navajas Y, Fernández-López J, Pérez-Alvarez JA. Functional properties of honey, propolis, and royal jelly. J Food Sci. 2008;73(9):R117-124.
• 66. Ramadan MF, Al-Ghamdi A. Bioactive compounds and health-promoting properties of royal jelly: A review. Journal of Functional Foods. 2012;4(1):39-52.
• 67. Xue X, Wu L, Wang K. Chemical Composition of Royal Jelly. In: Alvarez-Suarez JM, ed. Bee Products - Chemical and Biological Properties. Cham: Springer International Publishing; 2017:181-190.
• 68. Tamura T, Fujii A, Kuboyama N. [Antitumor effects of royal jelly (RJ)]. Nihon Yakurigaku Zasshi. 1987;89(2):73-80.
• 69. Fujiwara S, Imai J, Fujiwara M, Yaeshima T, Kawashima T, Kobayashi K. A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin. J Biol Chem. 1990;265(19):11333-11337.
• 70. Tokunaga KH, Yoshida C, Suzuki KM, et al. Antihypertensive effect of peptides from royal jelly in spontaneously hypertensive rats. Biol Pharm Bull. 2004;27(2):189-192.
• 71. Salazar-Olivo L, Paz-González V. Screening of biological activities present in honeybee (Apis mellifera) royal jelly. Toxicology in vitro. 2005;19(5):645-651.
• 72. Vucevic D, Melliou E, Vasilijic S, et al. Fatty acids isolated from royal jelly modulate dendritic cell-mediated immune response in vitro. Int Immunopharmacol. 2007;7(9):1211-1220.
• 73. Melliou E, Chinou I. Chapter 8 - Chemistry and Bioactivities of Royal Jelly. In: Atta ur R, ed. Studies in Natural Products Chemistry. Vol 43. Elsevier; 2014:261-290.
• 74. Guendouz M, Haddi A, Grar H, Kheroua O, Saidi D, Kaddouri H. Preventive effects of royal jelly against anaphylactic response in a murine model of cow's milk allergy. Pharm Biol. 2017;55(1):2145-2152.
• 75. Ahmad S, Campos MG, Fratini F, Altaye SZ, Li J. New Insights into the Biological and Pharmaceutical Properties of Royal Jelly. Int J Mol Sci. 2020;21(2).
• 76. Bălan A, Moga MA, Dima L, Toma S, Elena Neculau A, Anastasiu CV. Royal Jelly-A Traditional and Natural Remedy for Postmenopausal Symptoms and Aging-Related Pathologies. Molecules (Basel, Switzerland). 2020;25(14):3291.
• 77. Kunugi H, Mohammed Ali A. Royal Jelly and Its Components Promote Healthy Aging and Longevity: From Animal Models to Humans. Int J Mol Sci. 2019;20(19).
• 78. Bărnuțiu L, Mărghitaș L, Dezmirean D, Bobiș O, Mihai C, Pavel C. Physico-chemical composition of apilarnil (bee drone larvae). Lucrări Științifice-Universitatea de Științe Agricole Și Medicină Veterinară, Seria Zootehnie. 2013;59:199-202.
• 79. SİLİCİ S. Chemical Content and Bioactive Properties of Drone Larvae (Apilarnil). Mellifera. 2019;19(2):14-22.
• 80. Matsuka M, Watabe N, Takeuchi K. Analysis of the food of larval drone honeybees. Journal of Apicultural Research. 1973;12(1):3-7.
• 81. Balkanska R, Karadjova I, Ignatova M. Comparative analyses of chemical composition of royal jelly and drone brood. Proteins. 2014;16(1.29):14.65-18.33.
• 82. MARGAOAN R, MARGHITAS LA, DEZMIREAN DS, et al. Comparative study on quality parameters of royal jelly, Apilarnil and queen bee larvae triturate. Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Animal Science and Biotechnologies. 2017;74(1):51-58.
• 83. Ghosh S, Jung C, Meyer-Rochow VB. Nutritional value and chemical composition of larvae, pupae, and adults of worker honey bee, Apis mellifera ligustica as a sustainable food source. Journal of Asia-Pacific Entomology. 2016;19(2):487-495.
• 84. Sawczuk R, Karpinska J, Miltyk W. What do we need to know about drone brood homogenate and what is known. Journal of Ethnopharmacology. 2019;245:111581.
• 85. Doğanyiğit Z, Okan A, Kaymak E, Pandır D, Silici S. Investigation of protective effects of apilarnil against lipopolysaccharide induced liver injury in rats via TLR 4/ HMGB-1/ NF-κB pathway. Biomedicine & Pharmacotherapy. 2020;125:109967.
• 86. Park D, Jung JW, Lee MO, et al. Functional characterization of naturally occurring melittin peptide isoforms in two honey bee species, Apis mellifera and Apis cerana. Peptides. 2014;53:185-193.
• 87. Kolayli S, Keskin M. Chapter 7 - Natural bee products and their apitherapeutic applications. In: Atta ur R, ed. Studies in Natural Products Chemistry. Vol 66. Elsevier; 2020:175-196.
• 88. Hider RC. Honeybee venom: a rich source of pharmacologically active peptides. Endeavour. 1988;12(2):60-65.
• 89. Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Letters. 2017;402:16-31.
• 90. Banks B, Brown C, Burgess G, et al. Apamin blocks certain neurotransmitter-induced increases in potassium permeability. Nature. 1979;282(5737):415-417.
• 91. Shuba M, Vladimirova I. Effect of apamin on the electrical responses of smooth muscle to adenosine 5′-triphosphate and to non-adrenergic, non-cholinergic nerve stimulation. Neuroscience. 1980;5(5):853-859.
• 92. Varanda E, Tavares D. Radioprotection: mechanisms and radioprotective agents including honeybee venom. Journal of Venomous Animals and Toxins. 1998;4(1):5-21.
• 93. Raghuraman H, Chattopadhyay A. Melittin: a membrane-active peptide with diverse functions. Biosci Rep. 2007;27(4-5):189-223.
• 94. Chen J, Guan S-M, Sun W, Fu H. Melittin, the major pain-producing substance of bee venom. Neuroscience bulletin. 2016;32(3):265-272.
• 95. Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 2007;115(2):246-270.
• 96. Jim SY, Wittkowski KM. Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): a mast cell degranulating peptide mastoparan and phospholipase A1. International archives of allergy and immunology. 2003;131(1):25-32.
• 97. Shkenderov S, Koburova K. Adolapin-a newly isolated analgetic and anti-inflammatory polypeptide from bee venom. Toxicon. 1982;20(1):317-321.
• 98. Ye M, Chung H-S, Lee C, et al. Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease. Journal of neuroinflammation. 2016;13(1):1-12.
• 99. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proceedings of the National Academy of Sciences. 1995;92(12):5258-5265.
• 100. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015;136(5):E359-E386.
• 101. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-1953.
• 102. Zhang Y. Why do we study animal toxins? Zoological research. 2015;36(4):183.
• 103. Orsolic N. Bee venom in cancer therapy. Cancer Metastasis Rev. 2012;31(1-2):173-194.
• 104. Moon DO, Park SY, Heo MS, et al. Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt. Int Immunopharmacol. 2006;6(12):1796-1807.
• 105. Gajski G, Garaj-Vrhovac V. Melittin: A lytic peptide with anticancer properties. Environmental Toxicology and Pharmacology. 2013;36(2):697-705.
• 106. Raghuraman H, Chattopadhyay A. Melittin: a membrane-active peptide with diverse functions. Bioscience reports. 2007;27(4-5):189-223.
• 107. Premratanachai P, Chanchao C. Review of the anticancer activities of bee products. Asian Pacific journal of tropical biomedicine. 2014;4(5):337-344.
• 108. Jo M, Park MH, Kollipara PS, et al. Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol Appl Pharmacol. 2012;258(1):72-81.
• 109. Alonezi S, Tusiimire J, Wallace J, et al. Metabolomic Profiling of the Synergistic Effects of Melittin in Combination with Cisplatin on Ovarian Cancer Cells. Metabolites. 2017;7(2).
• 110. Lee HL, Park SH, Kim TM, et al. Bee venom inhibits growth of human cervical tumors in mice. Oncotarget. 2015;6(9):7280-7292.
• 111. Park MH, Choi MS, Kwak DH, et al. Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-kappaB. Prostate. 2011;71(8):801-812.
• 112. Ceremuga M, Stela M, Janik E, et al. Melittin—A Natural Peptide from Bee Venom Which Induces Apoptosis in Human Leukaemia Cells. Biomolecules. 2020;10(2):247.
• 113. Jang MH, Shin MC, Lim S, et al. Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J Pharmacol Sci. 2003;91(2):95-104.
• 114. Zheng J, Lee HL, Ham YW, Song HS, Song MJ, Hong JT. Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B. Oncotarget. 2015;6(42):44437-44451.